Probi AB
24
1
1
19
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 60/100
12.5%
3 terminated/withdrawn out of 24 trials
86.4%
-0.1% vs industry average
0%
0 trials in Phase 3/4
0%
0 of 19 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (24)
Effects of Probiotics on the Gut-brain Axis in Children
Role: lead
Probiotic Intervention for Gut Function
Role: lead
Probiotic Intervention for Occasional Constipation
Role: lead
Effect of Probiotic Supplements on Osteoarthritis Outcomes
Role: collaborator
Probiotic Intervention for Stress and Cognition
Role: lead
Changes of Oropharyngeal Flora
Role: collaborator
Probiotics in Radiation-treated Gynecologic Cancer
Role: lead
Efficacy of Probiotics on Iron Status During Pregnancy
Role: lead
Tolerance of a Probiotic Formula
Role: lead
Probiotic Intervention for Acute Stress
Role: lead
Efficacy of Probiotics on Physical Performance
Role: lead
The Efficacy of a Probiotic Product on Acute Upper Respiratory Tract Infections (Common Cold) in Healthy Children
Role: lead
Efficacy of a Probiotic Product in Children With Antibiotic-associated Gastrointestinal Disorders
Role: lead
Efficacy of Probiotics on Excessive Gas Accumulation
Role: lead
Chlorhexidine vs Lactobacillus Plantarum for Oral Care in Intubated ICU Patients
Role: collaborator
Probiotics Against Low Grade Inflammation and Increased Intestinal Permeability in the Elderly
Role: lead
Efficacy of a Probiotic Product on Bone Mineral Density (BMD) in Healthy Women in Early Post-menopausal Phase
Role: lead
Probiotics in Prevention of Common Cold
Role: lead
The Effect of Probiotics on Symptoms and Intestinal Flora in Patients With Irritable Bowel Syndrome
Role: lead
Benefit and Tolerability of a Probiotic Product in Infants With Abdominal Discomfort
Role: lead